Glycosaminoglycans: Participants in Microvascular Coagulation of Sepsis

Nanxi Li; Ruolin Hao; Peng Ren; Jingya Wang; Jiahui Dong; Tong Ye; Danyang Zhao; Xuan Qiao; Zhiyun Meng; Hui Gan; Shuchen Liu; Yunbo Sun; Guifang Dou; Ruolan Gu

doi:10.1055/a-2250-3166

Thrombosis and Haemostasis, Table of Contents

CC BY-NC-ND 4.0 · Thromb Haemost 2024; 124(07): 599-612
DOI: 10.1055/a-2250-3166

Review Article

Glycosaminoglycans: Participants in Microvascular Coagulation of Sepsis

Nanxi Li

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Ruolin Hao

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Peng Ren

²Beijing Institute of Basic Medical Sciences, Beijing, People Republic of China

,

Jingya Wang

²Beijing Institute of Basic Medical Sciences, Beijing, People Republic of China

,

Jiahui Dong

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Tong Ye

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Danyang Zhao

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Xuan Qiao

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Zhiyun Meng

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Hui Gan

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Shuchen Liu

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Yunbo Sun

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Guifang Dou

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

,

Ruolan Gu

¹Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, People Republic of China

› Author Affiliations

Abstract

Sepsis represents a syndromic response to infection and frequently acts as a common pathway leading to fatality in the context of various infectious diseases globally. The pathology of severe sepsis is marked by an excess of inflammation and activated coagulation. A substantial contributor to mortality in sepsis patients is widespread microvascular thrombosis-induced organ dysfunction. Multiple lines of evidence support the notion that sepsis induces endothelial damage, leading to the release of glycosaminoglycans, potentially causing microvascular dysfunction. This review aims to initially elucidate the relationship among endothelial damage, excessive inflammation, and thrombosis in sepsis. Following this, we present a summary of the involvement of glycosaminoglycans in coagulation, elucidating interactions among glycosaminoglycans, platelets, and inflammatory cells. In this section, we also introduce a reasoned generalization of potential signal pathways wherein glycosaminoglycans play a role in clotting. Finally, we discuss current methods for detecting microvascular conditions in sepsis patients from the perspective of glycosaminoglycans. In conclusion, it is imperative to pay closer attention to the role of glycosaminoglycans in the mechanism of microvascular thrombosis in sepsis. Dynamically assessing glycosaminoglycan levels in patients may aid in predicting microvascular conditions, enabling the monitoring of disease progression, adjustment of clinical treatment schemes, and mitigation of both acute and long-term adverse outcomes associated with sepsis.

Keywords

sepsis - glycosaminoglycans - thrombosis - inflammation - detection methods

Full Text

References

References
1 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 801-810
2 Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions. Geneva: World Health Organization; 2020
3 Rudd KE, Johnson SC, Agesa KM. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395 (10219): 200-211
4 Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet 2018; 392 (10141): 75-87
5 Tao Chen DW, Chen H, Yan W. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1295
6 Chao JY, Derespina KR, Herold BC. et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York City. J Pediatr 2020; 223: 14-19.e2
7 Eastin C, Eastin T. Clinical characteristics of coronavirus disease 2019 in China. J Emerg Med 2020; 58 (04) 711-712
8 López-Collazo E, Avendaño-Ortiz J, Martín-Quirós A, Aguirre LA. Immune response and COVID-19: a mirror image of sepsis. Int J Biol Sci 2020; 16 (14) 2479-2489
9 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062
10 Möckl L. The emerging role of the mammalian glycocalyx in functional membrane organization and immune system regulation. Front Cell Dev Biol 2020; 8: 253
11 Zhang X, Sun D, Song JW. et al. Endothelial cell dysfunction and glycocalyx - a vicious circle. Matrix Biol 2018; 71–72: 421-431
12 Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care 2019; 23 (01) 16
13 Sutherland TE, Dyer DP, Allen JE. The extracellular matrix and the immune system: a mutually dependent relationship. Science 2023; 379 (6633) eabp8964
14 Schmidt EP, Overdier KH, Sun X. et al. Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome. Am J Respir Crit Care Med 2016; 194 (04) 439-449
15 Shalaby S, Simioni P, Campello E. et al. Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis. Thromb Haemost 2020; 120 (08) 1173-1181
16 Cox D. Bacteria-platelet interactions. J Thromb Haemost 2009; 7 (11) 1865-1866
17 Palankar R, Kohler TP, Krauel K, Wesche J, Hammerschmidt S, Greinacher A. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA. J Thromb Haemost 2018; 16 (06) 1187-1197
18 Yang X, Cheng X, Tang Y. et al. Bacterial endotoxin activates the coagulation cascade through gasdermin D-dependent phosphatidylserine exposure. Immunity 2019; 51 (06) 983-996.e6
19 Ramlall V, Thangaraj PM, Meydan C. et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med 2020; 26 (10) 1609-1615
20 Doster RS, Rogers LM, Gaddy JA, Aronoff DM. Macrophage extracellular traps: a scoping review. J Innate Immun 2018; 10 (01) 3-13
21 Kim HJ, Sim MS, Lee DH. et al. Lysophosphatidylserine induces eosinophil extracellular trap formation and degranulation: implications in severe asthma. Allergy 2020; 75 (12) 3159-3170
22 Schmidt EP, Yang Y, Janssen WJ. et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 2012; 18 (08) 1217-1223
23 Aldabbous L, Abdul-Salam V, McKinnon T. et al. Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension. Arterioscler Thromb Vasc Biol 2016; 36 (10) 2078-2087
24 McCarthy CG, Saha P, Golonka RM, Wenceslau CF, Joe B, Vijay-Kumar M. Innate immune cells and hypertension: neutrophils and neutrophil extracellular traps (NETs). Compr Physiol 2021; 11 (01) 1575-1589
25 Wang H, Zhang H, Wang Y. et al. Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. J Hepatol 2021; 75 (06) 1271-1283
26 Foley JH. Examining coagulation-complement crosstalk: complement activation and thrombosis. Thromb Res 2016; 141 (Suppl. 02) S50-S54
27 De Backer D, Ortiz JA, Salgado D. Coupling microcirculation to systemic hemodynamics. Curr Opin Crit Care 2010; 16 (03) 250-254
28 Fernández-Sarmiento J, Salazar-Peláez LM, Carcillo JA. The endothelial glycocalyx: a fundamental determinant of vascular permeability in sepsis. Pediatr Crit Care Med 2020; 21 (05) e291-e300
29 de Bont CM, Boelens WC, Pruijn GJM. NETosis, complement, and coagulation: a triangular relationship. Cell Mol Immunol 2019; 16 (01) 19-27
30 Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 2021; 6 (01) 291
31 Kaur BP, Secord E. Innate immunity. Pediatr Clin North Am 2019; 66 (05) 905-911
32 Taguchi T, Mukai K. Innate immunity signalling and membrane trafficking. Curr Opin Cell Biol 2019; 59: 1-7
33 De Nardo D. Toll-like receptors: activation, signalling and transcriptional modulation. Cytokine 2015; 74 (02) 181-189
34 Hottz ED, Lopes JF, Freitas C. et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013; 122 (20) 3405-3414
35 Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets–an updated view. Mediators Inflamm 2013; 2013: 165974
36 Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11 (04) 264-274
37 Meziani F, Delabranche X, Asfar P, Toti F. Bench-to-bedside review: circulating microparticles–a new player in sepsis?. Crit Care 2010; 14 (05) 236
38 Nicolai L, Schiefelbein K, Lipsky S. et al. Vascular surveillance by haptotactic blood platelets in inflammation and infection. Nat Commun 2020; 11 (01) 5778
39 Gaertner F, Ahmad Z, Rosenberger G. et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 2017; 171 (06) 1368-1382.e23
40 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13 (01) 34-45
41 Lopes-Pires ME, Frade-Guanaes JO, Quinlan GJ. Clotting dysfunction in sepsis: a role for ROS and potential for therapeutic intervention. Antioxidants 2021; 11 (01) 88
42 Martín C, Ordiales H, Vázquez F. et al. Bacteria associated with acne use glycosaminoglycans as cell adhesion receptors and promote changes in the expression of the genes involved in their biosynthesis. BMC Microbiol 2022; 22 (01) 65
43 Clausen TM, Sandoval DR, Spliid CB. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 2020; 183 (04) 1043-1057.e15
44 Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021; 18 (09) 666-682
45 Padberg J-S, Wiesinger A, di Marco GS. et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 2014; 234 (02) 335-343
46 Rabelink TJ, de Zeeuw D. The glycocalyx–linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol 2015; 11 (11) 667-676
47 Rizzo ANSE, Schmidt EP. The role of the alveolar epithelial glycocalyx in acute respiratory distress syndrome. Am J Physiol Cell Physiol 2023; 324 (04) C799-C806
48 Rovas A, Seidel LM, Vink H. et al. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care 2019; 23 (01) 260
49 Bergmann S, Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007; 98 (03) 512-520
50 Wang Y, Zhao N, Jian Y. et al. The pro-inflammatory effect of Staphylokinase contributes to community-associated Staphylococcus aureus pneumonia. Commun Biol 2022; 5 (01) 618
51 Friedrich R, Panizzi P, Fuentes-Prior P. et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 2003; 425 (6957) 535-539
52 Zhang X, Lin L, Huang H, Linhardt RJ. Chemoenzymatic synthesis of glycosaminoglycans. Acc Chem Res 2020; 53 (02) 335-346
53 Shriver Z, Liu D, Sasisekharan R. Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc Med 2002; 12 (02) 71-77
54 Soares da Costa D, Reis RL, Pashkuleva I. Sulfation of glycosaminoglycans and its implications in human health and disorders. Annu Rev Biomed Eng 2017; 19 (01) 1-26
55 Smock RG, Meijers R. Roles of glycosaminoglycans as regulators of ligand/receptor complexes. Open Biol 2018; 8 (10) 180026
56 Koganti R, Memon A, Shukla D. Emerging roles of heparan sulfate proteoglycans in viral pathogenesis. Semin Thromb Hemost 2021; 47 (03) 283-294
57 Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol Heart Circ Physiol 2007; 292 (03) H1209-H1224
58 Pahakis MY, Kosky JR, Dull RO, Tarbell JM. The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. Biochem Biophys Res Commun 2007; 355 (01) 228-233
59 Hsieh HJLC, Liu CA, Huang B, Tseng AH, Wang DL. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci 2014; 21 (01) 3
60 Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 2003; 93 (10) e136-e142
61 Boo YCHJ, Hwang J, Sykes M. et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 2002; 283 (05) H1819-H1828
62 Bartosch AMW, Mathews R, Tarbell JM. Endothelial glycocalyx-mediated nitric oxide production in response to selective AFM pulling. Biophys J 2017; 113 (01) 101-108
63 Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ. Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 2002; 70 (07) 3602-3610
64 Iozzo RV, Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 2015; 42: 11-55
65 Li JP, Kusche-Gullberg M. Heparan sulfate: biosynthesis, structure, and function. Int Rev Cell Mol Biol 2016; 325: 215-273
66 Marques C, Reis CA, Vivès RR, Magalhães A. Heparan sulfate biosynthesis and sulfation profiles as modulators of cancer signalling and progression. Front Oncol 2021; 11: 778752
67 Tammi RH, Passi AG, Rilla K. et al. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 2011; 278 (09) 1419-1428
68 Lierova A, Kasparova J, Filipova A. et al. Hyaluronic acid: known for almost a century, but still in vogue. Pharmaceutics 2022; 14 (04) 838
69 Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455 (7213) 674-678
70 Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet 2019; 20 (11) 657-674
71 Clere-Jehl R, Mariotte A, Meziani F, Bahram S, Georgel P, Helms J. JAK-STAT targeting offers novel therapeutic opportunities in sepsis. Trends Mol Med 2020; 26 (11) 987-1002
72 O'Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013; 368 (02) 161-170
73 Goligorsky MS, Sun D. Glycocalyx in endotoxemia and sepsis. Am J Pathol 2020; 190 (04) 791-798
74 Eustes AS, Campbell RA, Middleton EA. et al. Heparanase expression and activity are increased in platelets during clinical sepsis. J Thromb Haemost 2021; 19 (05) 1319-1330
75 Lindahl U, Li J-P. Heparanase – discovery and targets. Adv Exp Med Biol 2020; 1221: 61-69
76 Johnson JL. Metalloproteinases in atherosclerosis. Eur J Pharmacol 2017; 816: 93-106
77 Becker BF, Jacob M, Leipert S, Salmon AHJ, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol 2015; 80 (03) 389-402
78 Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 2007; 80 (21) 1921-1943
79 Dogné S, Flamion B, Caron N. Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases. Arterioscler Thromb Vasc Biol 2018; 38 (07) 1427-1439
80 Sallisalmi M, Tenhunen J, Yang R, Oksala N, Pettilä V. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol Scand 2012; 56 (03) 316-322
81 Saoraya J, Wongsamita L, Srisawat N, Musikatavorn K. Plasma syndecan-1 is associated with fluid requirements and clinical outcomes in emergency department patients with sepsis. Am J Emerg Med 2021; 42: 83-89
82 Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care 2019; 23 (01) 16
83 Martin L, De Santis R, Koczera P. et al. The synthetic antimicrobial peptide 19-2.5 interacts with heparanase and heparan sulfate in murine and human sepsis. PLoS One 2015; 10 (11) e0143583
84 Nelson A, Berkestedt I, Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol Scand 2014; 58 (01) 36-43
85 Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014; 123 (18) 2768-2776
86 Visser M, Heitmeier S, Ten Cate H, Spronk HMH. Role of factor XIa and plasma kallikrein in arterial and venous thrombosis. Thromb Haemost 2020; 120 (06) 883-993
87 Norris LA. Blood coagulation. Best Pract Res Clin Obstet Gynaecol 2003; 17 (03) 369-383
88 Huntington JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 2003; 1 (07) 1535-1549
89 Pan J, Qian Y, Weiser P. et al. Glycosaminoglycans and activated contact system in cancer patient plasmas. Prog Mol Biol Transl Sci 2010; 93: 473-495
90 Deutsch E, Johnson SA, Seegers WH. Differentiation of certain platelet factors related to blood coagulation. Circ Res 1955; 3 (01) 110-115
91 Sartori MT, Zurlo C, Bon M. et al. Platelet-derived microparticles bearing PF4 and anti-GAGS immunoglobulins in patients with sepsis. Diagnostics (Basel) 2020; 10 (09) 627
92 Greinacher A, Holtfreter B, Krauel K. et al. Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease. Blood 2011; 118 (05) 1395-1401
93 Pouplard C, Rollin J, Gruel Y. Risk factors for heparin-induced thrombocytopenia: focus on Fcγ receptors. Thromb Haemost 2017; 116 (11) 799-805
94 Eslin DE, Zhang C, Samuels KJ. et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 2004; 104 (10) 3173-3180
95 Hayes V, Johnston I, Arepally GM. et al. Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia. J Clin Invest 2017; 127 (03) 1090-1098
96 Maroney SA, Mast AE. New insights into the biology of tissue factor pathway inhibitor. J Thromb Haemost 2015; 13 (0 1, Suppl 1): S200-S207
97 Bhakuni T, Ali MF, Ahmad I, Bano S, Ansari S, Jairajpuri MA. Role of heparin and non heparin binding serpins in coagulation and angiogenesis: a complex interplay. Arch Biochem Biophys 2016; 604: 128-142
98 Chao J, Schmaier A, Chen LM, Yang Z, Chao L. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. J Lab Clin Med 1996; 127 (06) 612-620
99 Chaaban H, Keshari RS, Silasi-Mansat R. et al. Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury. Blood 2015; 125 (14) 2286-2296
100 Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010; 87 (02) 300-310
101 dela Paz NG, Melchior B, Shayo FY, Frangos JA. Heparan sulfates mediate the interaction between platelet endothelial cell adhesion molecule-1 (PECAM-1) and the Gαq/11 subunits of heterotrimeric G proteins. J Biol Chem 2014; 289 (11) 7413-7424
102 Schabbauer G, Tencati M, Pedersen B, Pawlinski R, Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol 2004; 24 (10) 1963-1969
103 Cavaillon J-M, Adib-Conquy M. Monocytes/macrophages and sepsis. Crit Care Med 2005; 33 (12, Suppl): S506-S509
104 Wu C, Lu W, Zhang Y. et al. Inflammasome activation triggers blood clotting and host death through pyroptosis. Immunity 2019; 50 (06) 1401-1411.e4
105 Zhang H, Zeng L, Xie M. et al. TMEM173 drives lethal coagulation in sepsis. Cell Host Microbe 2020; 27 (04) 556-570.e6
106 Fang R, Jiang Q, Guan Y. et al. Golgi apparatus-synthesized sulfated glycosaminoglycans mediate polymerization and activation of the cGAMP sensor STING. Immunity 2021; 54 (05) 962-975.e8
107 Lentsch AB, Kato A, Davis B, Wang W, Chao C, Edwards MJ. STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia. J Clin Invest 2001; 108 (10) 1475-1482
108 Chen H, Sun H, You F. et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 2011; 147 (02) 436-446
109 Gotthardt D, Trifinopoulos J, Sexl V, Putz EM. JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front Immunol 2019; 10: 2590
110 Cavé MC, Maillard S, Hildenbrand K, Mamelonet C, Feige MJ, Devergne O. Glycosaminoglycans bind human IL-27 and regulate its activity. Eur J Immunol 2020; 50 (10) 1484-1499
111 Hasselbalch HC, Elvers M, Schafer AI. The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms. Blood 2021; 137 (16) 2152-2160
112 Beckman JD, DaSilva A, Aronovich E. et al. JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions. J Thromb Haemost 2023; 21 (05) 1366-1380
113 Xu D, Esko JD. Demystifying heparan sulfate-protein interactions. Annu Rev Biochem 2014; 83 (01) 129-157
114 Ricard-Blum S, Perez S. Glycosaminoglycan interaction networks and databases. Curr Opin Struct Biol 2022; 74: 102355
115 Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol 2004; 11 (09) 857-862
116 Tollefsen DM. Vascular dermatan sulfate and heparin cofactor II. Prog Mol Biol Transl Sci 2010; 93: 351-372
117 Shworak NW, Kobayashi T, de Agostini A, Smits NC. Anticoagulant heparan sulfate to not clot–or not?. Prog Mol Biol Transl Sci 2010; 93: 153-178
118 Ndonwi M, Burlingame OO, Miller AS, Tollefsen DM, Broze Jr GJ, Goldberg DE. Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II. Blood 2011; 117 (23) 6347-6354
119 Bray B, Lane DA, Freyssinet JM, Pejler G, Lindahl U. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Biochem J 1989; 262 (01) 225-232
120 Dinarvand P, Yang L, Biswas I, Giri H, Rezaie AR. Plasmodium falciparum histidine rich protein HRPII inhibits the anti-inflammatory function of antithrombin. J Thromb Haemost 2020; 18 (06) 1473-1483
121 Levi M, van der Poll T, Schultz M. Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost 2012; 38 (05) 506-514
122 Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol 2018; 14 (07) 417-427
123 Shimada K, Ozawa T, Kobayashi M. Human recombinant interleukin-1β- and tumor necrosis factor α-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells. J Cell Physiol 2005; 144 (03) 383-390
124 Maurer LM, Ma W, Mosher DF. Dynamic structure of plasma fibronectin. Crit Rev Biochem Mol Biol 2015; 51 (04) 213-227
125 Zhu J, Li X, Yin J, Hu Y, Gu Y, Pan S. Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats. J Cereb Blood Flow Metab 2018; 38 (11) 1979-1992
126 Pappa A, Jackson P, Stone J. et al. An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy. Eye (Lond) 1998; 12 (Pt 2): 237-244
127 Goffin YA, de Gouveia RH, Szombathelyi T, Toussaint JM, Gruys E. Morphologic study of homograft valves before and after cryopreservation and after short-term implantation in patients. Cardiovasc Pathol 1997; 6 (01) 35-42
128 Inagawa R, Okada H, Takemura G. et al. Ultrastructural alteration of pulmonary capillary endothelial glycocalyx during endotoxemia. Chest 2018; 154 (02) 317-325
129 Chappell D, Jacob M, Hofmann-Kiefer K. et al. Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 2009; 83 (02) 388-396
130 Chappell D, Jacob M, Paul O. et al. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ Res 2009; 104 (11) 1313-1317
131 Groner W, Winkelman JW, Harris AG. et al. Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 1999; 5 (10) 1209-1212
132 Nieuwdorp M, Meuwese MC, Mooij HL. et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol 2008; 104 (03) 845-852
133 Ando Y, Okada H, Takemura G. et al. Brain-specific ultrastructure of capillary endothelial glycocalyx and its possible contribution for blood brain barrier. Sci Rep 2018; 8 (01) 17523
134 Massey MJ, Shapiro NI. A guide to human in vivo microcirculatory flow image analysis. Crit Care 2016; 20 (01) 35
135 Xiao S, Tang Y, Lin Y, Lv Z, Chen L. Tracking osteoarthritis progress through cationic nanoprobe-enhanced photoacoustic imaging of cartilage. Acta Biomater 2020; 109: 153-162
136 Pomin VH. NMR-based dynamics of free glycosaminoglycans in solution. Analyst (Lond) 2014; 139 (15) 3656-3665
137 Manzi AE, Norgard-Sumnicht K, Argade S, Marth JD, van Halbeek H, Varki A. Exploring the glycan repertoire of genetically modified mice by isolation and profiling of the major glycan classes and nano-NMR analysis of glycan mixtures. Glycobiology 2000; 10 (07) 669-689
138 Dekker NAM, Veerhoek D, Koning NJ. et al. Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass. Anaesthesia 2019; 74 (05) 609-618
139 Bush MA, Florence SM, Yeo TW. et al. Degradation of endothelial glycocalyx in Tanzanian children with falciparum malaria. FASEB J 2021; 35 (09) e21805
140 Kuźnik-Trocha K, Winsz-Szczotka K, Komosińska-Vassev K. et al. Plasma and urine levels of glycosaminoglycans in patients with systemic sclerosis and their relationship to selected interleukins and marker of early kidney injury. J Clin Med 2022; 11 (21) 6354
141 Qiao M, Lin L, Xia K, Li J, Zhang X, Linhardt RJ. Recent advances in biotechnology for heparin and heparan sulfate analysis. Talanta 2020; 219: 121270
142 Wang Z, Dhurandhare VM, Mahung CA. et al. Improving the sensitivity for quantifying heparan sulfate from biological samples. Anal Chem 2021; 93 (32) 11191-11199
143 Bratulic S, Limeta A, Dabestani S. et al. Noninvasive detection of any-stage cancer using free glycosaminoglycans. Proc Natl Acad Sci U S A 2022; 119 (50) e2115328119
144 Sun X, Li L, Overdier KH. et al. Analysis of total human urinary glycosaminoglycan disaccharides by liquid chromatography-tandem mass spectrometry. Anal Chem 2015; 87 (12) 6220-6227
145 Bratulic S, Limeta A, Maccari F. et al. Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults. J Biol Chem 2022; 298 (02) 101575
146 Wang Z, Arnold K, Dhurandahare VM. et al. Analysis of 3-O-sulfated heparan sulfate using isotopically labeled oligosaccharide calibrants. Anal Chem 2022; 94 (06) 2950-2957
147 Li G, Li L, Tian F, Zhang L, Xue C, Linhardt RJ. Glycosaminoglycanomics of cultured cells using a rapid and sensitive LC-MS/MS approach. ACS Chem Biol 2015; 10 (05) 1303-1310
148 Pimienta G, Heithoff DM, Rosa-Campos A. et al. Plasma proteome signature of sepsis: a functionally connected protein network. Proteomics 2019; 19 (05) e1800389
149 Weiss RJ, Spahn PN, Chiang AWT. et al. Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate. Nat Chem Biol 2021; 17 (06) 684-692
150 Toledo AG, Golden G, Campos AR. et al. Proteomic atlas of organ vasculopathies triggered by Staphylococcus aureus sepsis. Nat Commun 2019; 10 (01) 4656
151 Golden GJ, Toledo AG, Marki A. et al. Endothelial heparan sulfate mediates hepatic neutrophil trafficking and injury during Staphylococcus aureus sepsis. MBio 2021; 12 (05) e0118121
152 Volpi N, Linhardt RJ. High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides. Nat Protoc 2010; 5 (06) 993-1004
153 Volpi N, Galeotti F, Yang B, Linhardt RJ. Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection. Nat Protoc 2014; 9 (03) 541-558
154 Miller RL, Guimond SE, Schwörer R. et al. Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides. Nat Commun 2020; 11 (01) 1481
155 Hook AL, Hogwood J, Gray E, Mulloy B, Merry CLR. High sensitivity analysis of nanogram quantities of glycosaminoglycans using ToF-SIMS. Commun Chem 2021; 4 (01) 67
156 Clerc O, Deniaud M, Vallet SD. et al. MatrixDB: integration of new data with a focus on glycosaminoglycan interactions. Nucleic Acids Res 2019; 47 (D1): D376-D381
157 Hogan JD, Klein JA, Wu J. et al. Software for peak finding and elemental composition assignment for glycosaminoglycan tandem mass spectra. Mol Cell Proteomics 2018; 17 (07) 1448-1456
158 Duan J, Pepi L, Amster IJ. A scoring algorithm for the automated analysis of glycosaminoglycan MS/MS data. J Am Soc Mass Spectrom 2019; 30 (12) 2692-2703
159 Karlsson R, Chopra P, Joshi A. et al. Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates. Sci Adv 2021; 7 (52) eabl6026
160 Zhang F, Lee KB, Linhardt RJ. SPR biosensor probing the interactions between TIMP-3 and heparin/GAGs. Biosensors (Basel) 2015; 5 (03) 500-512
161 Kim SY, Jin W, Sood A. et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Antiviral Res 2020; 181: 104873
162 Shi D, He P, Song Y. et al. Kinetic and structural aspects of glycosaminoglycan-monkeypox virus protein A29 interactions using surface plasmon resonance. Molecules 2022; 27 (18) 5898
163 Salek-Ardakani S, Arrand JR, Shaw D, Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 2000; 96 (05) 1879-1888
164 Ambrosius M, Kleesiek K, Götting C. Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J Chromatogr A 2008; 1201 (01) 54-60
165 Yang B, Chang Y, Weyers AM, Sterner E, Linhardt RJ. Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry. J Chromatogr A 2012; 1225: 91-98
166 Song S, Yu Q, Zhang B. et al. Quantification and comparison of acidic polysaccharides in edible fish intestines and livers using HPLC-MS/MS. Glycoconj J 2017; 34 (05) 625-632
167 Kozak RP, Tortosa CB, Fernandes DL, Spencer DI. Comparison of procainamide and 2-aminobenzamide labeling for profiling and identification of glycans by liquid chromatography with fluorescence detection coupled to electrospray ionization-mass spectrometry. Anal Biochem 2015; 486: 38-40
168 Wang DLF. Identification of heparin and heparan sulfate by HILIC-MS /MS. Shandong Daxue Xuebao Yixue Ban 2021; 59: 41-47
169 Šimek M, Hermannová M, Šmejkalová D. et al. LC-MS/MS study of in vivo fate of hyaluronan polymeric micelles carrying doxorubicin. Carbohydr Polym 2019; 209: 181-189
170 Karlsson NG, Schulz BL, Packer NH, Whitelock JM. Use of graphitised carbon negative ion LC-MS to analyse enzymatically digested glycosaminoglycans. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 824 (1–2): 139-147
171 Osago H, Shibata T, Hara N. et al. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal Biochem 2014; 467: 62-74
172 Forni G, Malvagia S, Funghini S. et al. LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization. Clin Chim Acta 2019; 488: 98-103
173 Turiák L, Tóth G, Ozohanics O. et al. Sensitive method for glycosaminoglycan analysis of tissue sections. J Chromatogr A 2018; 1544: 41-48
174 Logsdon AF, Francis KL, Richardson NE. et al. Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain. Alzheimers Dement 2022; 18 (05) 942-954
175 Wang J, Bhalla A, Ullman JC. et al. High-throughput liquid chromatography-tandem mass spectrometry quantification of glycosaminoglycans as biomarkers of mucopolysaccharidosis II. Int J Mol Sci 2020; 21 (15) 5449